Aci Chempharma Technology is categorized under Business Services (Unclassified) in Brighton, MA and active since 2008.
Aci Chempharma Technology was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Dongli Chen at the company’s single location by writing to 2031 Commonwealth Avenue, Brighton, Massachusetts MA 02135 or by phoning (281) 579-3104. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aci Chempharma Technology |
| Contact Person: | Dongli Chen |
| Address: | 2031 Commonwealth Avenue, Brighton, Massachusetts 02135 |
| Phone Number: | (281) 579-3104 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Aci Chempharma Technology was started in 2008 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dongli Chen for inquiries that concern Aci Chempharma Technology by calling the company number (281) 579-3104, as your correspondence is most welcome. Additionally, the physical location of the single location of Aci Chempharma Technology can be found at the coordinates as well as the street address 2031 Commonwealth Avenue in Brighton, Massachusetts 02135.
For its online presence, you may visit Aci Chempharma Technology’s website at and engage with its social media outlets through on Twitter and on Facebook.